Braskem SA reported a significant 76% increase in recurring EBITDA to $192 million for Q1 2026 compared to Q4 2025. This improvement is attributed to higher product demand and effective cost management.
AI Assistant
BRASKEM SA
2026
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.